Keynote Address (10´) : AIOS – AWARD, 2017 ( INFLAMMATION ) Recombinant Interferon Alfa 2B for OSSN : An Efficient and Cost Effective Treatment Modality for Asian Indian Patients.
Keynote Address (10´) : AIOS – AWARD, 2017 ( INFLAMMATION ) Recombinant Interferon Alfa 2B for OSSN : An Efficient and Cost Effective Treatment Modality for Asian Indian Patients.
Leave a Comment